Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study

被引：0
作者：
Mei Li
Zhenlin Zhang
Qingyun Xue
Qifu Li
Xiaolan Jin
Jin Dong
Qun Cheng
Li You
Hua Lin
Hai Tang
Lin Shen
Xin Gao
Ji Hu
Aijun Chao
Pengqiu Li
Rui Shi
Shuhui Zheng
Ying Zhang
Xiaojiang Xiong
Wei Yu
Weibo Xia
机构：
[1] Chinese Academy of Medical Sciences,Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital
[2] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of Osteoporosis and Bone Disease
[3] Beijing Hospital,Department of Orthopaedics
[4] National Center of Gerontology,Department of Endocrinology
[5] The First Affiliated Hospital of Chongqing Medical University,Department of Endocrinology
[6] Western Theater Command General Hospital,Department of Endocrinology
[7] The First Affiliated Hospital of Shanxi Medical University,Department of Osteoporosis and Bone Disease
[8] Huadong Hospital Affiliated to Fudan University,Department of Endocrinology and Metabolism, Shanghai General Hospital
[9] Shanghai Jiao Tong University,Department of Orthopaedics, Nanjing Drum Tower Hospital
[10] The Affiliated Hospital of Nanjing University Medical School,Department of Orthopedics, Beijing Friendship Hospital
[11] Capital Medical University,Department of Integrated of Traditional Chinese and Western Medicine, Union Hospital
[12] Tongji Medical College of Huazhong University of Science and Technology,Department of Endocrinology, Zhongshan Hospital
[13] Fudan University,Department of Obstetrics and Gynecology
[14] The Second Affiliated Hospital of Soochow University,Department of Orthopaedics
[15] Tianjin Hospital,Department of Endocrinology
[16] Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital,Department of Orthopedics, West China Hospital
[17] Sichuan University,Department of Orthopaedics
[18] Heibei General Hospital,Department of Endocrinology
[19] The Third Affiliated Hospital of Guangzhou Medical University,Department of Orthopedics Joint Disease Area
[20] Chongqing Three Gorges Central Hospital,Department of Radiology, Peking Union Medical College Hospital
[21] Chinese Academy of Medical Sciences,Department of Endocrinology, Key Laboratory of Endocrinology, NHC, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital
[22] Chinese Academy of Medical Sciences,undefined
来源：
Archives of Osteoporosis | 2022年 / 17卷
关键词：
Teriparatide; Alendronate; Postmenopausal osteoporosis; Bone mineral density; Bone turnover markers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 157 条
  • [1] Gao C(2019)Prevalence of osteoporotic vertebral fracture among community-dwelling elderly in Shanghai Chin Med J (Engl) 132 1749-1751
  • [2] Xu Y(2021)Prevalence of osteoporosis and fracture in China: the China osteoporosis prevalence study JAMA Netw Open 4 e2121106-99
  • [3] Li L(2020)Incidence of and trends in hip fracture among adults in urban China: a nationwide retrospective cohort study PLoS Med 17 e1003180-376
  • [4] Wang L(2022)The impact of the reference pricing policy in China on drug procurement and cost Health Policy Plan 37 73-11
  • [5] Yu W(2019)Osteoporosis Lancet 393 364-46
  • [6] Yin X(2019)Teriparatide versus bisphosphonates for treatment of postmenopausal osteoporosis: A meta-analysis Int J Surg 66 1-1148
  • [7] Zhang C(2020)American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 UPDATE Endocr Pract 26 1-1443
  • [8] Feng J(1993)Vertebral fracture assessment using a semiquantitative technique J Bone Miner Res 8 1137-610
  • [9] Wang S(1995)Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group N Engl J Med 333 1437-290
  • [10] Jiang B(2000)Alendronate for the treatment of osteoporosis in men N Engl J Med 343 604-478
12345678910